BNP Paribas Financial Markets’s Cyclerion Therapeutics CYCN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15 | Hold |
5
| – | – | ﹤0.01% | 4584 |
|
|
2025
Q1 | $12 | Hold |
5
| – | – | ﹤0.01% | 4498 |
|
|
2024
Q4 | $16 | Buy |
+5
| New | +$16 | ﹤0.01% | 4501 |
|
|
2023
Q2 | – | Sell |
-5
| Closed | -$39 | – | 3295 |
|
|
2023
Q1 | $39 | Sell |
5
-11
| -69% | -$86 | ﹤0.01% | 3168 |
|
|
2022
Q4 | $208 | Hold |
16
| – | – | ﹤0.01% | 3258 |
|
|
2022
Q3 | $273 | Hold |
16
| – | – | ﹤0.01% | 3869 |
|
|
2022
Q2 | $174 | Buy |
16
+2
| +14% | +$22 | ﹤0.01% | 3362 |
|
|
2022
Q1 | $319 | Hold |
14
| – | – | ﹤0.01% | 3482 |
|
|
2021
Q4 | $494 | Hold |
14
| – | – | ﹤0.01% | 3462 |
|
|
2021
Q3 | $881 | Buy |
14
+3
| +27% | +$189 | ﹤0.01% | 3279 |
|
|
2021
Q2 | $881 | Sell |
11
-396
| -97% | -$31.7K | ﹤0.01% | 3352 |
|
|
2021
Q1 | $22.7K | Buy |
407
+184
| +83% | +$10.3K | ﹤0.01% | 3169 |
|
|
2020
Q4 | $13.7K | Sell |
223
-38
| -15% | -$2.33K | ﹤0.01% | 3242 |
|
|
2020
Q3 | $31.8K | Buy |
261
+196
| +302% | +$23.9K | ﹤0.01% | 3043 |
|
|
2020
Q2 | $7.72K | Sell |
65
-307
| -83% | -$36.5K | ﹤0.01% | 3192 |
|
|
2020
Q1 | $19.7K | Buy |
372
+192
| +107% | +$10.2K | ﹤0.01% | 3300 |
|
|
2019
Q4 | $9.82K | Buy |
180
+36
| +25% | +$1.96K | ﹤0.01% | 3457 |
|
|
2019
Q3 | $34.8K | Buy |
144
+53
| +58% | +$12.8K | ﹤0.01% | 3043 |
|
|
2019
Q2 | $20.8K | Buy |
+91
| New | +$20.8K | ﹤0.01% | 3255 |
|